Article
Human neutralizing antibodies target a conserved lateral patch on H7N9 hemagglutinin head
27 May 2024
Abstract excerpt
Avian influenza A virus H7N9 causes severe human infections with >30% fatality. Currently, there is no H7N9-specific prevention or treatment for humans. Here, from a 2013 H7N9 convalescent case in Hong Kong, we isolate four hemagglutinin (HA)-reactive monoclonal antibodies (mAbs), with three directed to the globular head domain (HA1) and one to the stalk domain (HA2). Two clonally related HA1-directed mAbs,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
